2. Explosive M & A Activity
• Recent Mega Mergers ($17.9B) –
Elanco/Novartis & BI/Merial
• 2015: 50 Deals of varied sizes and sectors
(Source: AnimalPharm)
• Vaccines a hot target
4. Food Animal: The Paradigm Shifted
• Regulatory environment and customer
demands favor shift to preventatives and
non-antibiotic therapy alternatives.
• Attractive categories:
– Vaccines
– Probiotics
– Bacteriophage
– GMO
– Next gen plant-based parasiticides
5. Product Development
• Large company product development is being
outpaced by market demand for alternative products
• New products and technology required. Radical
innovation as opposed to incremental.
– Start-ups will provide much of the input
• Innovative products/companies are prime targets for
acquisition
• There is a shortage of quality product alternatives to
address HUGE needs
6. Animal Health Innovation Support
• KC Animal Health Corridor Observations
– Built in advantage. Legacy industry presence
– Two major agriculture universities within 150 miles
each direction. KSU and University of Missouri
– Diverse animal health coalition
• Animal Health Innovation Support Concept
– Identify existing/near-term companies
– Leverage cooperation with another agriculture
university (Purdue)
– Choose an area of focus. Example: Food animal
vaccines, antibiotic alternatives, etc.
